Roelof Botha Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 11 hours ago
Roelof Botha has an estimated net worth of at least $216.9 million*, as of Feb. 12, 2025. They own 1.2 million shares of NTRA stock. They have sold 114,473 shares of NTRA stock since 2021, for an estimated $9.8 million.
Roelof Botha $NTRA SEC Form 4 Insider Trading
Roelof Botha has filed a total of 8 insider trades in $NTRA since 2021. Their most recent trade was a sale of 8,783 shares, made on Dec 02, 2024. Their largest trade was a purchase of 85,903 shares, made on Mar 16, 2022. We estimate that they now own 1.2 million shares of $NTRA, worth an estimated $207.1 million.
Insider Trading at $NTRA
There have been a total of 663 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 3.3 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 1,632 shares reported by Solomon Moshkevich (PRESIDENT, CLINICALDIAGNOSTICS), made on Feb 06, 2025.
History of Insider Stock Trades by Roelof Botha
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NTRA
|
Sale | 8,783 | Dec 02, 2024 | Dec. 4, 2024, 6:13 p.m. |
|
NTRA
|
Sale | 10,447 | Dec 02, 2024 | Dec. 4, 2024, 6:13 p.m. |
|
NTRA
|
Sale | 16,853 | Dec 02, 2024 | Dec. 4, 2024, 6:13 p.m. |
|
NTRA
|
Sale | 40,171 | Dec 02, 2024 | Dec. 4, 2024, 6:13 p.m. |
|
NTRA
|
Sale | 11,219 | Dec 02, 2024 | Dec. 4, 2024, 6:13 p.m. |
SQ
|
Purchase | 313,139 | Aug 06, 2024 | Aug. 8, 2024, 6:41 p.m. |
|
SQ
|
Purchase | 121,266 | Aug 06, 2024 | Aug. 8, 2024, 6:41 p.m. |
MDB
|
Sale | 2,500 | Mar 13, 2024 | March 15, 2024, 4:41 p.m. |
|
MDB
|
Sale | 13,999 | Mar 13, 2024 | March 15, 2024, 4:41 p.m. |
|
MDB
|
Sale | 4,936 | Mar 13, 2024 | March 15, 2024, 4:41 p.m. |
|
MDB
|
Sale | 3,543 | Mar 13, 2024 | March 15, 2024, 4:41 p.m. |
|
MDB
|
Sale | 300 | Mar 13, 2024 | March 15, 2024, 4:41 p.m. |
|
MDB
|
Sale | 1,722 | Mar 13, 2024 | March 15, 2024, 4:41 p.m. |
|
SQ
|
Purchase | 495,539 | Nov 08, 2023 | Nov. 13, 2023, 6:41 p.m. |
|
SQ
|
Purchase | 6,412 | Nov 09, 2023 | Nov. 13, 2023, 6:41 p.m. |
|
SQ
|
Purchase | 15,262 | Nov 10, 2023 | Nov. 13, 2023, 6:41 p.m. |
|
SQ
|
Purchase | 23,433 | Nov 13, 2023 | Nov. 13, 2023, 6:41 p.m. |
|
NTRA
|
Purchase | 85,903 | Mar 16, 2022 | March 18, 2022, 7:34 p.m. |
|
NTRA
|
Purchase | 26,402 | Mar 16, 2022 | March 18, 2022, 7:34 p.m. |
|
NTRA
|
Purchase | 40,695 | Mar 16, 2022 | March 18, 2022, 7:34 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.